Literature DB >> 21670240

Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective.

Karen A Hicks, Norman L Stockbridge, Shari L Targum, Robert J Temple.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21670240     DOI： 10.1161/CIRCULATIONAHA.111.032433

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.

Authors:  S Harada; Y Zhou; S Duncan; A R Armstead; G M Coshatt; C Dillon; B C Brott; J Willig; J A Alsip; W B Hillegass; N A Limdi
Journal:  Clin Pharmacol Ther       Date:  2017-06-01       Impact factor: 6.875

2.  Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index.

Authors:  David R Dobies; Kimberly R Barber; Amanda L Cohoon
Journal:  Open Heart       Date:  2015-02-10

3.  Should We Maintain Anticoagulation after Successful Radiofrequency Catheter Ablation of Atrial Fibrillation? The Need for a Randomized Study.

Authors:  Giuseppe Santarpia; Salvatore De Rosa; Jolanda Sabatino; Antonio Curcio; Ciro Indolfi
Journal:  Front Cardiovasc Med       Date:  2017-12-21

4.  Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis.

Authors:  Oh Hyun Lee; Byeong Keuk Kim; Sung Jin Hong; Seunghwan Kim; Chul Min Ahn; Dong Ho Shin; Jung Sun Kim; Tae Soo Kang; Young Guk Ko; Donghoon Choi; Myeong Ki Hong; Yangsoo Jang
Journal:  Yonsei Med J       Date:  2020-07       Impact factor: 2.759

5.  Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study.

Authors:  Ying Yao; Ping Wang; Xiao-Zeng Wang; Xin Zhao; Wei Zhao; Tie-Nan Zhou; Lei Zhang
Journal:  Chin Med J (Engl)       Date:  2019-10-05       Impact factor: 2.628

6.  Venous Thromboembolism in Patents With Lung Cancer.

Authors:  Takahito Suzuki; Susumu Fujino; Shouta Inaba; Ryo Yamamura; Hiromasa Katoh; Yoshihiro Noji; Masato Yamaguchi; Takahiko Aoyama
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

7.  Which is the best for the warfarin monitoring: Following up by fixed or variable physician?

Authors:  Lale Dinc Asarcikli; Habibe Kafes; Taner Sen; Esra Gucuk Ipek; Osman Beton; Ahmet Temizhan; Mehmet Birhan Yilmaz
Journal:  North Clin Istanb       Date:  2022-03-10

8.  Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.

Authors:  Yahya Dadjou; Salar Safavi; Javad Kojuri
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

9.  Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry.

Authors:  Mohammad Zubaid; Haitham Khraishah; Barrak Alahmad; Wafa Rashed; Mustafa Ridha; Fahad Alenezi; Mohamad Aljarralah; Khalid Al-Marri; Mohammad Almutairi; Khalid Althalji; Abdulhamied Alfaddagh
Journal:  Ann Glob Health       Date:  2020-02-05       Impact factor: 2.462
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.